233 related articles for article (PubMed ID: 36756140)
1. Retracted: MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway.
Engineering JOH
J Healthc Eng; 2023; 2023():9873529. PubMed ID: 36756140
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway.
Ma L; Tao C; Zhang Y
J Healthc Eng; 2022; 2022():7026174. PubMed ID: 35075389
[TBL] [Abstract][Full Text] [Related]
3. RETRACTED: Lai et al. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling.
Lai CY; Yeh KY; Lin CY; Hsieh YW; Lai HH; Chen JR; Hsu CC; Her GM
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672694
[TBL] [Abstract][Full Text] [Related]
4. Retracted: A Study on Curcumol Influencing Proliferation and Apoptosis of Hepatocellular Carcinoma Cells through DJ-1/PTEN/PI3K/AKT Pathway.
International BR
Biomed Res Int; 2024; 2024():9781784. PubMed ID: 38230006
[TBL] [Abstract][Full Text] [Related]
5. Retracted: Ginsenoside Rg1 Suppresses Non-Small-Cell Lung Cancer via MicroRNA-126-PI3K-AKT-mTOR Pathway.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9769574. PubMed ID: 38125075
[TBL] [Abstract][Full Text] [Related]
6. Retracted: MicroRNA-1179 regulates proliferation and chemosensitivity of human ovarian cancer cells by targeting the PTEN-mediated PI3K/AKT signaling pathway.
Zhihong Z; Rubin C; Liping L; Anpeng M; Hui G; Yanting W; Zhenxiu S
Arch Med Sci; 2023; 19(2):557. PubMed ID: 37034514
[TBL] [Abstract][Full Text] [Related]
7. microRNA-17 is a tumor suppressor in oral squamous cell carcinoma and is repressed by LSD1.
Wangzhou K; Fu W; Li M; Lu Z; Lai Z; Liu C; Tan Y; Hao C
Oral Dis; 2023 Mar; 29(2):491-504. PubMed ID: 34152066
[TBL] [Abstract][Full Text] [Related]
8. microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction].
Cancer Manag Res; 2021; 13():4765. PubMed ID: 34163251
[TBL] [Abstract][Full Text] [Related]
9. Retracted: A Molecular Mechanism Study to Reveal Hirudin's Downregulation to PI3K/AKT Signaling Pathway through Decreasing PDGFR
International BR
Biomed Res Int; 2023; 2023():9809487. PubMed ID: 38188746
[TBL] [Abstract][Full Text] [Related]
10. [Retracted] MicroRNA‑451a prevents cutaneous squamous cell carcinoma progression via the 3‑phosphoinositide‑dependent protein kinase‑1‑mediated PI3K/AKT signaling pathway.
Fu J; Zhao J; Zhang H; Fan X; Geng W; Qiao S
Exp Ther Med; 2024 Jul; 28(1):280. PubMed ID: 38800047
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma.
Markers D
Dis Markers; 2023; 2023():9756735. PubMed ID: 37502574
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
13. Retracted: DDTC Suppresses Ovarian Cancer Development via the PI3K/AKT/mTOR Signaling Pathway.
Markers D
Dis Markers; 2023; 2023():9810565. PubMed ID: 37502573
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9824504. PubMed ID: 37886318
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.
Markers D
Dis Markers; 2023; 2023():9849123. PubMed ID: 37593569
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p.
Lu P; Jiang Y; Xia Z
Anticancer Drugs; 2023 Jan; 34(1):144-154. PubMed ID: 36539367
[TBL] [Abstract][Full Text] [Related]
17. Retracted: BAP31 Promotes Proliferation, Invasion, and Metastasis of Liver Cancer Cells via Activating PI3K/AKT Pathway.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9864562. PubMed ID: 37476776
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Pingyangmycin Activates Oral Carcinoma Cell Autophagy via the Phosphorylation of the PI3K/AKT/mTOR Axis to Achieve the Purpose of Treating Oral Carcinoma.
International EM
Emerg Med Int; 2024; 2024():9795172. PubMed ID: 38298946
[TBL] [Abstract][Full Text] [Related]
19. Retracted: MicroRNA-4325 Suppresses Cell Progression in Hepatocellular Carcinoma via GATA-Binding Protein 6.
International BR
Biomed Res Int; 2024; 2024():9802639. PubMed ID: 38230017
[TBL] [Abstract][Full Text] [Related]
20. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
